Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Paul B. Koller · SciRah

Researcher profile · Semantic Scholar

Paul B. Koller

Share profile

Paul B. Koller — researcher profile on SciRah

h-index: 15
Works: 153
Citations: 1,029

Most-cited papers

Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia
Amir T. Fathi, Alexander E. Perl, Geoffrey Fell, Brian A. Jonas +31 more
2025Blood46 citations
Semantic Scholar
TP53 mutations are associated with CD19− relapse and inferior outcomes after blinatumomab in adults with ALL
I. Aldoss, Shanpeng Li, Jian-Ying Zhang, Mary C. Clark +26 more
2025Blood Advances19 citations Open access
Semantic Scholar
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
I. Aldoss, Jian-Ying Zhang, Kathryn Shimamoto, C. Saygin +27 more
2024Haematologica15 citations Open access
Semantic Scholar
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions
I. Aldoss, M. Afkhami, Dong-Yun Yang, Zhaohui Gu +26 more
2023American journal of hematology/oncology15 citations Open access
Semantic Scholar
Olverembatinib (HQP1351) Overcomes Ponatinib Resistance in Patients with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
E. Jabbour, Paul B. Koller, V. Oehler, Omer H. Jamy +14 more
2022Blood15 citations Open access
Semantic Scholar
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity
Paul B. Koller, Natalia Baran, Karine Harutyunyan, Antonio Cavazos +11 more
2023Journal for ImmunoTherapy of Cancer13 citations Open access
Semantic Scholar
Update of Olverembatinib (HQP1351) Overcoming Ponatinib and/or Asciminib Resistance in Patients (Pts) with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph + ALL)
E. Jabbour, H. Kantarjian, Paul B. Koller, Omer H. Jamy +20 more
2023Blood13 citations Open access
Semantic Scholar
Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)
B. Ball, Shukaib Arslan, Paul B. Koller, Dat Ngo +17 more
2022Leukemia and Lymphoma13 citations
Semantic Scholar
Dose-escalation of second-line and first-line asciminib in chronic myeloid leukemia in chronic phase: the ASC2ESCALATE Phase II trial
E. Atallah, Michael J. Mauro, K. Sasaki, M. Y. Levy +6 more
2024Future Oncology12 citations Open access
Semantic Scholar
Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity
Xian Sun, Wei-Jan Wang, Ji-Lu Lang, Riyao Yang +12 more
2023International Journal on Biological Sciences12 citations Open access
Semantic Scholar
Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
N. Daver, K. Lee, Yunsuk Choi, B. Jonas +15 more
2023Blood12 citations
Semantic Scholar
Post-transplant sinusoidal obstruction syndrome in adult patients with B-cell Acute Lymphoblastic Leukemia treated with pre-transplant Inotuzumab.
V. Agrawal, H. Pourhassan, N. Tsai, Dat Ngo +22 more
2023Transplantation and Cellular Therapy11 citations Open access
Semantic Scholar
Tocilizumab for Cytokine Release Syndrome Management after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
Janny M. Yao, Salman Otoukesh, Hanna Kim, Dong-Yun Yang +22 more
2023Transplantation and Cellular Therapy10 citations Open access
Semantic Scholar
CD19-CAR T cell therapy as a definitive consolidation in older adults with b-ALL in CR1 is safe and induces durable MRD- remission
I. Aldoss, Xiu-Li Wang, Jian-Ying Zhang, Min Guan +19 more
2025Blood8 citations
Semantic Scholar
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy.
I. Aldoss, Haoyue Shan, Dong-Yun Yang, Mary C. Clark +18 more
2024Transplantation and Cellular Therapy8 citations Open access
Semantic Scholar
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high‐grade hepatotoxicity without adversely impacting outcomes
J. Tinajero, Sharon Xu, Dat Ngo, Shanpeng Li +12 more
2024British Journal of Haematology8 citations
Semantic Scholar
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T‐cell therapy in Philadelphia chromosome‐positive acute lymphoblastic leukaemia
T. Othman, Paul B. Koller, H. Pourhassan, Vaibhav Agrawal +11 more
2024British Journal of Haematology7 citations
Semantic Scholar
A Phase 1a/b Trial of Luxeptinib (CG-806) in Patients with Relapsed/Refractory B-Cell Malignancies or Acute Myeloid Leukemia and Evaluation of New G3 Formulation
A. Goldberg, F. Samaniego, M. Ohanian, Paul B. Koller +25 more
2023Blood7 citations Open access
Semantic Scholar
A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-like B-cell Acute Lymphoblastic Leukemia in First Complete Remission.
Z. Rahman, T. Othman, R. Saliba, Yenny Alejandra Moreno Vanegas +19 more
2024Transplantation and Cellular Therapy6 citations Open access
Semantic Scholar
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia
T. Othman, Paul B. Koller, N. Tsai, Dong-Yun Yang +22 more
2024American journal of hematology/oncology6 citations
Semantic Scholar
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib
Dat Ngo, J. Tinajero, Shanpeng Li, Joycelynne Palmer +10 more
2024Leukemia and Lymphoma6 citations
Semantic Scholar
Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy
I. Aldoss, Haoyue Shan, Dong-Yun Yang, Mary C. Clark +19 more
2023Blood6 citations Open access
Semantic Scholar
The Role of Transplant for Philadelphia-positive B-cell Acute Lymphoblastic Leukemia in 2025
Vaibhav Agrawal, Paul B. Koller, A. Stein, V. Pullarkat +1 more
2025Current Oncology Reports5 citations
Semantic Scholar
Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxis
Diana T. Samuels, Janny M. Yao, Yazeed Samara, Dong-Yun Yang +26 more
2025Frontiers in Immunology5 citations Open access
Semantic Scholar
A Multicenter Analysis of Allogeneic Transplant Outcomes in Patients with Philadelphia-like (Ph-like) Acute Lymphoblastic Leukemia (ALL)
Zaid H. Abdel Rahman, Paul B. Koller, T. Othman, R. Saliba +19 more
2023Blood5 citations Open access
Semantic Scholar
The efficacy of targeted and immune‐based therapies in adults with TP53‐mutated acute lymphoblastic leukaemia
H. Pourhassan, J. Tinajero, Hui-Yan Ma, Ryan N. Jackson +18 more
2025British Journal of Haematology4 citations
Semantic Scholar
The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B‐cell precursor acute lymphoblastic leukaemia in measurable residual disease‐negative remission
J. Tinajero, Dat Ngo, Maria C. Motta, Vaibhav Agrawal +9 more
2025British Journal of Haematology4 citations
Semantic Scholar
Covalent-103: A phase 1, open-label, dose-escalation and expansion study of BMF-500, an oral covalent FLT3 inhibitor, in adults with acute leukemia (AL).
Marcello Rotta, Yasmin M. Abaza, H. Carraway, Bradley Christensen +14 more
2024Journal of Clinical Oncology4 citations
Semantic Scholar
Hypomethylating agent and venetoclax are effective salvage therapies in relapsed/refractory early T‐cell precursor acute lymphoblastic leukaemia
Vaibhav Agrawal, Shukaib Arslan, H. Pourhassan, Paul B. Koller +2 more
2025British Journal of Haematology3 citations
Semantic Scholar
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect
Paul B. Koller, T. Othman, Dong-Yun Yang, S. Mokhtari +23 more
2025Bone Marrow Transplantation3 citations Open access
Semantic Scholar
Total Body Irradiation and Fludarabine with Post-Transplant Cyclophosphamide for Mismatched Related or Unrelated Donor HCT
Shukaib Arslan, Amrita Desai, Dong-Yun Yang, S. Mokhtari +23 more
2024Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia
Dat Ngo, J. Tinajero, Joo Y. Song, Hui-Yan Ma +10 more
2024Leukemia and Lymphoma3 citations
Semantic Scholar
Therapy‐related acute lymphoblastic leukaemia in women with antecedent breast cancer
H. Pourhassan, Jian-Ying Zhang, J. Tinajero, V. Pullarkat +11 more
2024British Journal of Haematology3 citations
Semantic Scholar
Eculizumab Treatment Outcomes in Patients with Allogeneic Hematopoietic Cell Transplant (alloHCT)-Associated Thrombotic Microangiopathy (TA-TMA): A Retrospective Single-Center Experience
Yazeed Samara, Janny M. Yao, N. Tsai, S. Mokhtari +26 more
2024Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In Relapsed and Refractory Acute Myeloid Leukemia Patients
J. Tinajero, Dat Ngo, A. Salhotra, Paul B. Koller
2023Acta Haematologica3 citations
Semantic Scholar
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B‐ALL With High Disease Burden
J. Tinajero, Kim-Son Nguyen, Dat Ngo, Vaibhav Agrawal +12 more
2025American journal of hematology/oncology2 citations
Semantic Scholar
Asciminib (ASC) in chronic myeloid leukemia in chronic Phase (CML-CP): Efficacy and safety results of the Phase 2 ASC2ESCALATE trial in the cohort of patients (pts) with 1 prior tyrosine kinase inhibitor (TKI)
Jorge E. Cortes, E. Atallah, D. Andorsky, Marlise R. Luskin +18 more
2025Blood2 citations
Semantic Scholar
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis
A. Salhotra, Dong-Yun Yang, M. A. Al Malki, S. Mokhtari +22 more
2025Bone Marrow Transplantation2 citations Open access
Semantic Scholar
Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia
Dat Ngo, J. Tinajero, Jian-Ying Zhang, A. Stein +7 more
2024Journal of Oncology Pharmacy Practice2 citations Open access
Semantic Scholar
Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation.
Amrita Desai, Yazeed Samara, Dong-Yun Yang, B. Ball +22 more
2024Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis2 citations
Semantic Scholar
Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)
H. Pourhassan, Tina Nguyen, Dong-Yun Yang, Salman Otoukesh +20 more
2024Cancers2 citations Open access
Semantic Scholar
Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience
I. Amanam, Janny M. Yao, Alfredo G. Puing, N. Tsai +20 more
2023Cancer Medicine2 citations Open access
Semantic Scholar
Covalent-103: A Phase 1, Open-Label, Dose-Escalation, and Dose-Expansion Study of Bmf-500, an Oral Covalent FLT3 Inhibitor, in Adults with Acute Leukemia (AL)
Marcello Rotta, F. Ravandi, M. Gandhi, Paul B. Koller +7 more
2023Blood2 citations Open access
Semantic Scholar
Ponatinib, asciminib and inotuzumab ozogamicin: A novel drug combination in acute lymphoblastic leukemia.
J. Tinajero, H. Ali, Paul B. Koller
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis2 citations
Semantic Scholar
ASC2ESCALATE: A Phase 2, Single-Arm, Dose-Escalation Study of Asciminib Monotherapy in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with 1 Prior Tyrosine Kinase Inhibitor (TKI)
K. Sasaki, M. Mauro, M. Levy, E. Atallah +6 more
2022Blood2 citations Open access
Semantic Scholar
CAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission
I. Aldoss, Lior Goldberg, Jian-Ying Zhang, Andy Artz +27 more
2026Blood Advances1 citations Open access
Semantic Scholar
Single Center phase 1b Study of Orca-T Following Escalated Doses of Total Marrow and Lymphoid Irradiation (TMLI) in Patients with Acute Leukemia or MDS
A. Salhotra, S. Dandapani, Dong-Yun Yang, S. Mokhtari +11 more
2026Transplantation and Cellular Therapy1 citations
Semantic Scholar
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation.
J. R. Ramos Perez, Haoyue Shan, Dong-Yun Yang, L. Chien +27 more
2026Transplantation and Cellular Therapy1 citations
Semantic Scholar
Asciminib (ASC) in chronic myeloid leukemia in chronic Phase (CML-CP): Interim analysis (IA) efficacy and safety results of the Phase 2 ASC2ESCALATE trial in the cohort of newly diagnosed (1L) patients (pts)
M. Levy, D. Andorsky, CelesteAnn T. Bremer, J. Zeidner +22 more
2025Blood1 citations
Semantic Scholar
Outpatient Brexucabtagene Autoleucel in B‐Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma
T. Othman, John H. Baird, Yan Wang, S. Pak +13 more
2025American journal of hematology/oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Aldoss×32
Invite
I. Aldoss — researcher profile on SciRah
V. Pullarkat×29
Invite
V. Pullarkat — researcher profile on SciRah
H. Pourhassan×27
Invite
H. Pourhassan — researcher profile on SciRah
A. Salhotra×26
Invite
A. Salhotra — researcher profile on SciRah

×25

Invite

Guido Marcucci — researcher profile on SciRah

Vaibhav Agrawal×25

Invite

Vaibhav Agrawal — researcher profile on SciRah

Invite

A. Aribi — researcher profile on SciRah

M. A. Al Malki×21

Invite

M. A. Al Malki — researcher profile on SciRah

Invite

H. Ali — researcher profile on SciRah

Karamjeet S. Sandhu×20

Invite

Karamjeet S. Sandhu — researcher profile on SciRah

Shukaib Arslan×18

Invite

Shukaib Arslan — researcher profile on SciRah

Invite

B. Ball — researcher profile on SciRah